These compounds may interact with:
Receptor-type tyrosine-protein kinase FLT3
Potentially involved in: cancer; immune system cancer; lymphoid leukemia; lung cancer; kidney cancer; carcinoma; skin cancer; neutropenia; anemia; acute lymphocytic leukemia; acute biphenotypic leukemia; leukemia, myelocytic, acute; acute myelomonocytic leukemia; acute promyelocytic leukemia; acute myeloid leukemia, m1; thrombosis; acute myeloid leukemia (aml-m2); b- and t-cell mixed leukemia; all; acute t cell leukemia
Disease data sourced from Pharos.